Menu

Braze, Inc. (BRZE)

$29.77
+0.39 (1.34%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$3.1B

Enterprise Value

$2.9B

P/E Ratio

N/A

Div Yield

0.00%

Rev Growth YoY

+25.8%

Rev 3Y CAGR

+35.6%

Company Profile

At a glance

OfferFit Acquisition Transforms the Thesis: Braze's $325 million acquisition of OfferFit in June 2025 pivots the company from a customer engagement platform into an AI decisioning platform, adding reinforcement learning capabilities that legacy competitors cannot easily replicate. This creates a deeper technical moat and higher average contract values (exceeding $250,000) but will be modestly dilutive to non-GAAP operating margins in fiscal 2026 before returning to the company's margin expansion framework in fiscal 2027.

Consumption Model Evolution Reduces Friction: Braze's expansion of its flexible credit model to include email, content cards, banners, and audience management—combined with a "massive relaxation" of data point limits—directly addresses the highest friction points in its pricing. This accelerates sales cycles and enables customer experimentation, with 58.8% of Q2 subscription growth coming from new customers and 41.2% from existing customer expansion.

Margin Expansion Framework Intact Despite Investment: The company delivered its third straight quarter of non-GAAP net income profitability in Q4 FY2025 and is guiding to 3.5% non-GAAP operating margins for FY2026, a 350 basis point improvement year-over-year. While the OfferFit integration creates a temporary departure from the long-term margin framework, management remains committed to driving higher profitability while thoughtfully reinvesting in the business.

Price Chart

Loading chart...

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks